Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients

The outbreak of the COVID-19 pandemic has spread throughout the world, affecting almost all nations and territories. The current double-blind, randomized, placebo-controlled, phase II clinical trial sought to evaluate the clinical efficacy and safety of mebendazole as an adjuvant therapy for outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Tanani, Mohamed, Ahmed, Khaled Abdul-Aziz, Shakya, Ashok K., Ammari, Wesam G., Al-Shudifat, Abdel-Elah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300804/
https://www.ncbi.nlm.nih.gov/pubmed/37375747
http://dx.doi.org/10.3390/ph16060799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300804/
https://www.ncbi.nlm.nih.gov/pubmed/37375747
http://dx.doi.org/10.3390/ph16060799

Ejemplares similares